. Author manuscript; available in PMC: 2014 Jan 1.

Published in final edited form as: Nutr Metab Cardiovasc Dis. 2011 May 12;23(1):38–45. doi: 10.1016/j.numecd.2011.02.004

Table 3.

General characteristics of the study population

	No-MetS (n=1775 )	HD (n=328)	DD (n=512)

Age (yrs)	42.7±13.5	51.6±11.2^*	50.6±12.3^*
BMI (kg/m²)	28.6±6.4	33.1±6.7^*	33.9±6.9^*
Waist (cm)	95±16	108±14^*	110±14^*
Diastolic BP (mmHg)	71.7±11.2	70.7±8.9^†	75.8±11^*.4
Systolic BP (mmHg)	121.0±19.4	122.4±14.4^†	135.6±20.8^*
Duration of hypertension (yrs)	13.7±10.1	13.0±9.8^†	16.0±11.2^*
Duration of antihypertensive therapy (yrs)	12.5±9.6	11.4±8.8^†	14.5±10.1^*
Heart rate (bpm)	66.0±10.6	68.7±11.8^*	69.9±11.4^*
Creatinine (mg/dL)	0.96±0.20	0.97±0.21	0.97±0.20
Cholesterol (mg/dL)	187.6±37.9	199.5±40.8^*^†	207.0±38.5^*
HDL-cholesterol (mg/dL)	54.9±15.2	48.2±12.0^*^†	41.7±10.9^*
LDL-cholesterol (mg/dL)	113.7±34.3	123.7±34.0^*	126.5±35.2^*
Triglycerides (mg/dL)	94.8±51.6	139.3±66.9^*^†	203.3±102.9^*
Fasting glucose (mg/dL)	90.7±9.2	96.5±12.9^*^†	108.0±11.8^*
Fasting insulin (μUI/L)	7.1±5.4	10.8±9.1^*^†	13.0±11.8^*
HOMA_r index	1.6±1.3	2.6±2.4^*^†	3.6±4.0^*

p<0.05 vs. No MetS;

^†

p<0.05 vs DD.

DD=diagnosis of MetS based on direct measurements of the components.

HD=diagnosis of MetS based on historical exposition, with one or more treated components of the MetS normal at the time of survey.